Dipna Pharmachem Limited (BSE: 543594) is an Ahmedabad, Gujarat-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹11 Cr, it ranks #4,731 by market cap among the 6,197 Indian listed companies on FinBizNet, and #12 of 13 in Pharmaceutical Product Distribution. At ₹4.39 (as of 16 Nov 2026), the share price is 77.9% below its 52-week high of ₹19.90 and 21.3% above its 52-week low of ₹3.62. The share price is down 77.1% over one year and down 13.9% over three months.
| Current Price | ₹4.39 |
|---|---|
| Market Cap | ₹11 Cr |
| BSE Code | 543594 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 4.3 |
| Return on Equity | 4.22% |
| Return on Assets | 1.84% |
| 52-Week Range | ₹3.62 – ₹19.90 |
| 1-Year Price Change | -77.1% |
| 3-Month Price Change | -13.9% |
| Beta (1Y) | 0.5 |
| Headquarters | Ahmedabad, Gujarat |
| Website | dipnapharmachem.com |
| Revenue | ₹2 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 8.9% |
| EPS (Basic) | ₹0.07 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Delivery averaged 90.1% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Dipna Pharmachem Limited imports, trades in, and exports pharmaceutical products primarily in India. It offers industrial chemicals, pharmaceutical raw materials, excipients, solvents, active pharmaceutical ingredients, formulations, and intermediates. The company was incorporated in 2011 and is based in Ahmedabad, India.
1. PharmaceLrtical-This segment engages in the trading of pharmaceutical products. 2. Chemicals-NA 3. Steel-NA 4. NA-NA
1. PharmaceLrtical-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Entero Healthcare Solutions Limited | ₹8,733 Cr | 74.6 | 8.28% | ₹2,087 Cr | +80.7% |
| Remus Pharmaceuticals Limited | ₹941 Cr | 26.1 | 13.78% | — | +0.6% |
| Health X Platform Limited (Sastasundar Ventures Ltd) | ₹871 Cr | 752.7 | -0.18% | ₹484 Cr | -5.7% |
| Aptus Pharma Limited | ₹837 Cr | 156.8 | — | — | +754.0% |
| Vasa Denticity Limited | ₹797 Cr | 76.5 | 6.68% | ₹87 Cr | -21.4% |
| Bijoy Hans Ltd | ₹523 Cr | — | — | — | +128.4% |
| Speciality Medicines Limited | ₹149 Cr | 11.5 | — | — | — |
| Vijaypd Ceutical Limited | ₹136 Cr | 23 | 9.53% | — | — |
| Dipna Pharmachem Limited | ₹11 Cr | 4.3 | 4.22% | ₹2 Cr | -77.1% |
Listed by market capitalisation. Ratios are shown for context only.
Dipna Pharmachem Limited is trading at ₹4.39, with a market capitalisation of ₹11 Cr.
Dipna Pharmachem Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Dipna Pharmachem Limited has a P/E of 4.3 and a return on equity of 4.22%.
Dipna Pharmachem Limited is listed on the BSE under the scrip code 543594.
Dipna Pharmachem Limited's share price is down 77.1% over one year and down 13.9% over three months. Its 52-week range is ₹3.62 to ₹19.90.
In Q4 FY26, Dipna Pharmachem Limited reported revenue of ₹2 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.07 (standalone, parsed from the company's exchange filing).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.